BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20196171)

  • 21. Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis.
    He X; Pang Z; Zhang X; Lan T; Chen H; Chen M; Yang H; Huang J; Chen Y; Zhang Z; Jing W; Peng R; Zhang H
    Am J Surg Pathol; 2018 Sep; 42(9):1143-1155. PubMed ID: 30001240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.
    Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
    Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
    Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.
    Reifenberger G; Reifenberger J; Ichimura K; Meltzer PS; Collins VP
    Cancer Res; 1994 Aug; 54(16):4299-303. PubMed ID: 8044775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma.
    Ragazzini P; Gamberi G; Benassi MS; Orlando C; Sestini R; Ferrari C; Molendini L; Sollazzo MR; Merli M; Magagnoli G; Bertoni F; Bohling T; Pazzagli M; Picci P
    Cancer Detect Prev; 1999; 23(2):129-36. PubMed ID: 10101594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.
    Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
    J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases.
    Ricciotti RW; Baraff AJ; Jour G; Kyriss M; Wu Y; Liu Y; Li SC; Hoch B; Liu YJ
    Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative genomic hybridization of low-grade central osteosarcoma.
    Tarkkanen M; Böhling T; Gamberi G; Ragazzini P; Benassi MS; Kivioja A; Kallio P; Elomaa I; Picci P; Knuutila S
    Mod Pathol; 1998 May; 11(5):421-6. PubMed ID: 9619593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parosteal osteosarcoma.
    Hang JF; Chen PC
    Arch Pathol Lab Med; 2014 May; 138(5):694-9. PubMed ID: 24786129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate.
    Lonardo F; Ueda T; Huvos AG; Healey J; Ladanyi M
    Cancer; 1997 Apr; 79(8):1541-7. PubMed ID: 9118036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
    Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL
    Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDM2/CDK4 gene amplification in large/deep-seated 'lipomas': incidence, predictors and clinical significance.
    Wong DD; Low IC; Peverall J; Robbins PD; Spagnolo DV; Nairn R; Carey-Smith RL; Wood D
    Pathology; 2016 Apr; 48(3):203-9. PubMed ID: 27020493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.
    Amoroso L; Ognibene M; Morini M; Conte M; Di Cataldo A; Tondo A; D'Angelo P; Castellano A; Garaventa A; Lasorsa VA; Podestà M; Capasso M; Pezzolo A
    Genes Chromosomes Cancer; 2020 May; 59(5):277-285. PubMed ID: 31756773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
    Khatib ZA; Matsushime H; Valentine M; Shapiro DN; Sherr CJ; Look AT
    Cancer Res; 1993 Nov; 53(22):5535-41. PubMed ID: 8221695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.
    Wikman H; Nymark P; Väyrynen A; Jarmalaite S; Kallioniemi A; Salmenkivi K; Vainio-Siukola K; Husgafvel-Pursiainen K; Knuutila S; Wolf M; Anttila S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):193-9. PubMed ID: 15543620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
    Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
    Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
    Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
    Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
    Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
    Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
    Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM
    J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.